More Post from the Author
- Global Military Products Awarded Contract Exceeding $635 Million for 155mm Artillery Munitions
- SJE Acquires AMI Global, Expanding Industrial Internet of Things (IIoT) Capabilities
- Lumenuity Selected as Finalist for Pepperdine's Most Fundable Companies of 2025
- APhA alarmed by claims of harm from acetaminophen without substantive science
- Exiger Named Presenting Sponsor Of Navy 250 Gala Celebrating Navy & Marine Corps' 250th Anniversary
AdventHealth Tampa is first in Tampa Bay to offer implantable chemotherapy pump for patients with metastatic colorectal cancer
Published on Wed 19 Mar 2025 9:40:06 UTC

Hepatic Artery Infusion therapy delivers treatment directly tometastatic tumors in the liver, while minimizing the potential for systemic side effects
TAMPA, Fla., March 18, 2025 /PRNewswire/ -- AdventHealth Tampa is the first in the Tampa Bay area to offer a powerful new pump-based treatment option for colorectal cancer that has spread to the liver and for a rare form of cancer that forms in bile ducts within the liver called intrahepatic cholangiocarcinoma.
Hepatic Artery Infusion (HAI) therapy uses a pump that is implanted just below the skin in a patient's abdominal wall to deliver medicine directly to the liver through the hepatic artery, maximizing drug delivery to the tumors without adding systemic side effects.
More Post from the Author
- Global Military Products Awarded Contract Exceeding $635 Million for 155mm Artillery Munitions
- SJE Acquires AMI Global, Expanding Industrial Internet of Things (IIoT) Capabilities
- Lumenuity Selected as Finalist for Pepperdine's Most Fundable Companies of 2025
- APhA alarmed by claims of harm from acetaminophen without substantive science
- Exiger Named Presenting Sponsor Of Navy 250 Gala Celebrating Navy & Marine Corps' 250th Anniversary